resources

CORONA Remedies Ltd.

NSE: CORONA

BSE: 544644

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2,022.80+43.4 (+2.19%)

9 Jul, 3:30 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

CORONA Remedies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2025	2026
Annual Reports	—	FY 2026
Quarterly Results	Sept Dec	Mar
Conference Calls	—	12Jan 10Feb 18May
Presentations	—	3Jan 2Feb 11May

Corporate Announcements and Regulatory Filings

CORONA Remedies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

AGM9 Jul 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 22nd Annual General Meeting
General6 Jul 2026
Compliances-Certificate Under Reg. 74(5) Of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the first quarter ended June 30, 2026
Press Release / Media Release30 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Commencement of Commercial Production
General30 Jun 2026
Commencement Of Commercial Production
Intimation under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015-Commencement of Commercial Production
Closure of Trading Window29 Jun 2026
Closure of Trading Window
Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies Limited in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd & Others
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd & Others
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Newspaper Publication16 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Notice of 22nd Annual General Meeting , Intimation of Record Date and E-voting information
General15 Jun 2026
Communication To Shareholders
Communication to Shareholders - Annual Report 2025-26
Business Responsibility and Sustainability Reporting (BRSR)15 Jun 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting for the F.Y. 2025-26
General15 Jun 2026
Regulation 34(1)-Annual Report
Annual Report for the F.Y. 2025-26
AGM15 Jun 2026
Notice Of 22Nd Annual General Meeting
Notice of 22nd Annual General Meeting scheduled to be held on Thursday, July 09, 2026
Newspaper Publication10 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Intimation of 22nd Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means (VC / OAVM) facility
Analyst / Investor Meet10 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Schedule of Analysts / Investor Conference
Analyst / Investor Meet3 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Non-Deal Roadshow
Analyst / Investor Meet1 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Non-Deal Roadshow
Press Release / Media Release28 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Receipt of EU-GMP Certification
General21 May 2026
General-Updates
Communication to Shareholders - Intimation on Tax Deduction on Dividend

Frequently Asked Questions

Where can I download the annual report of CORONA Remedies Ltd.?

Annual reports of CORONA Remedies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of CORONA Remedies Ltd.?

Quarterly earnings results and presentations of CORONA Remedies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does CORONA Remedies Ltd. publish earnings call transcripts?

Earnings call transcripts of CORONA Remedies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of CORONA Remedies Ltd.?

Investor presentations and annual day presentations of CORONA Remedies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of CORONA Remedies Ltd.?

Corporate announcements and regulatory filings of CORONA Remedies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of CORONA Remedies Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of CORONA Remedies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of CORONA Remedies Ltd.?

The ISIN (International Securities Identification Number) of CORONA Remedies Ltd. is INE02ZQ01018. This is the unique identifier used across exchanges and depositories.

On which stock exchange is CORONA Remedies Ltd. listed?

CORONA Remedies Ltd. is listed on NSE and BSE. The NSE symbol is CORONA and the BSE code is -.

Where can I find the shareholding pattern of CORONA Remedies Ltd.?

The quarterly shareholding pattern of CORONA Remedies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for CORONA Remedies Ltd. on Sharpely?

Share price data for CORONA Remedies Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.